Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection by Camila A Corsini, Priscilla S Filgueiras, Nathalie BF Almeida, Daniel AP de Miranda, Sarah VC Gomes, Adelina Junia Lourenço, Cecilia MF Bicalho, Jessica V de Assis, Raquel NH Amorim, Raphael A Silva, Raquel VR Vilela, Tulio M Lima, Daniel PB de Abreu, Renata GF Alvim, Leda R Castilho, Olindo A Martins-Filho, Dayane A Otta, Rafaella FQ Grenfell

Get full text

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One... by Rafaella F. Q. Grenfell, Rafaella F. Q. Grenfell, Nathalie B. F. Almeida, Nathalie B. F. Almeida, Priscilla S. Filgueiras, Camila A. Corsini, Sarah V. C. Gomes, Daniel A. P. de Miranda, Adelina J. Lourenço, Olindo A. Martins-Filho, Jaquelline G. de Oliveira, Andrea Teixeira-Carvalho, Guilherme R. F. Campos, Mauricio L. Nogueira, Mauricio L. Nogueira, Mauricio L. Nogueira, Pedro Augusto Alves, Gabriel R. Fernandes, Gabriel R. Fernandes, Leda R. Castilho, Tulio M. Lima, Daniel P. B. de Abreu, Renata G. F. Alvim, Thaís Bárbara de S. Silva, Wander de J. Jeremias, Dayane A. Otta, Ana Carolina Campi-Azevedo, Immunita-001 Team, Priscila Fernanda S Martins, Maria Luysa C Pedrosa, Jessica V de Assis, Viviane CF dos Santos, Eduardo R de Oliveira, Raphael A Silva, Maria Izabella VARC Medeiros, Rafaela OV Coelho, Cecilia MF Bicalho, Raquel VR Vilela

Get full text